模块化实验室自动化市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

在预测期内，模块化实验室自动化市场预计将以 6.5% 的复合年增长率增长。

实验室自动化通过用全自动系统稳步取代半自动化和手动方法改变了医学实验室空间。这些自动化系统有利于无菌环境，大大减少人为错误并节省时间。常规实验室流程（例如测试和筛选）是自动化的。自动化工具实时处理并发请求，显着提高生产力和吞吐量。

主要亮点

• 市场即将扩张的主要原因之一是实验室自动化带来的好处越来越多。从完全手动干预到实验室自动化的范式转变对临床实验室具有许多优势。可靠的结果、安全的工作环境、更高的生产力以及显着的时间、空间和成本节约只是其中一些关键优势。实验室自动化通过使实验室设备更易于用于重复过程（例如样品检查和试管贴标）、减少或限制人工操作，从而节省实验室成本和空间。
• 预计新兴市场将在预测期内为实验室自动化产品的製造商和分销商提供巨大的增长潜力。对临床诊断过程的需求增加正在推动实验室自动化设备的销售增长。领先的产品製造商正在扩大其在新地区的销售网络和生产能力，以增加市场份额。这显示了实验室自动化的盈利潜力。
• 在模块化实验室环境中，液体处理器和机械臂在提高效率的同时执行各种任务变得越来越方便。相反，自动化工具还可以满足系统执行特定任务的需求，例如运行 ELISA 检测。
• 近年来，分子诊断分析严重依赖实时 PCR 技术。它使用荧光报告器在 PCR 进行时实时检测 DNA 扩增。诊所中超过 75% 的分子诊断测试适用于实时 PCR。该技术通过提供快速检测来更好地诊断复杂疾病和个性化治疗，从而引发了一个新的分子生物学市场。
• 此外，在早期癌症检测中使用实验室自动化工具以及在微生物学中的日益普及是北美和欧洲市场增长的主要驱动力。 MLA（医学实验室助理）工具已在印度和中国等新兴市场广泛用于诊断，预计对这些工具的需求将稳步上升。
• COVID-19 大流行加速了药物开发和研究，同时给临床实验室和製药公司带来了额外压力。因此，对□标仪、自动液体处理和机器人技术的兴趣使缩短 TAT 成为优先事项。同时，疫情降低了医院和医疗机构的收入和利润，减少了自动化和技术方面的支出。因此，它影响了模块化实验室自动化的长期市场。

主要市场趋势

自动液体处理器占有最大的市场份额

• 液体处理器通常用于生物化学和化学实验室。自动化液体处理机器人有助于在实验室分配样品和其他液体。自动化的液体处理器可以最大限度地缩短运行时间并最大限度地提高准确性。此外，液体处理器可以在很宽的纳升体积范围内运行，证明了它们在分配任务中的有用性。
• 领先公司不断投资开发优质产品，为自动液体处理器开发树立标桿并有效提高生产力。能够处理微量液体的液体处理器的发展促进了市场上模块化实验室自动化系统的快速发展。
• 根据机器人行业协会的数据，自动化液体处理机、自动化板式处理机和机械臂等工业机器人是生命科学领域增长第三快的细分市场，满足了需求。
• Parker 表示，生命科学领域的机器人趋势之一是简化机器人分析仪中的流体。这种趋势源于这样一个事实，即临床实验室和医院在处理关键样本时无法停止设备。机器人系统，过去在移液单元的尖端有 50 根针头并使用了许多管子，最近使用了一种特殊的阀组，可以消除对管子的需求并减少故障的可能性。我来了。这种歧管基本上可以将洩漏的可能性降到最低。

预计亚太地区将实现强劲增长

• 由于製药市场的快速增长，预计亚太地区对实验室自动化解决方案的需求将会增加。这一增长归因于亚太地区对药物研发的投资增加。
• 在亚太地区，长期的经济和人口趋势、进一步的医疗改革以及政府五年计划中阐明的政策预计将推动市场增长。高增长的市场为实验室自动化解决方案供应商提供了新的立足点。
• 例如，从药品到医疗产品再到消费者健康，中国仍然是世界上最具吸引力的市场之一，并且是迄今为止增长最快的大型新兴市场。儘管最近有所下降，但它仍然是亚太地区模块化实验室自动化的重要市场。
• 此外，与其他大陆不同，该地区拥有许多异质的人口群体，非常适合进行药物研究。由于拥有熟练的劳动力和药物开发的低成本，该地区是外包药物研究的首选目的地。
• 许多组织正在采用模块化实验室，以提供低成本、可靠的解决方案。模块化实验室自动化在市场上的需求不断增加。韩国有望成为技术先进的国家之一。预计本地公司更多地采用自动化和技术创新将推动该行业的增长。

竞争格局

模块化实验室自动化市场是分散的。随着全球临床和临床前研究的数量迅速增加，迫切需要更快的样本分析。它减少了机器停机时间和人力。随着需求的增加，公司正在进入市场，使其具有吸引力和竞争力。市场参与者包括 Thermo Fisher Scientific、Danaher Corporation、Becton Dickinson、Siemens Healthcare、Synchron Lab Automation、Honeywell International Inc.、Perkinelmer Inc. 等公司。

• 2021 年 3 月 - PerkinElmer 推出了一套完整的工作流程解决方案，包括仪器、试剂和耗材，用于检测和筛选 SARS-CoV-2 RNA。模块化的自动化工作站与可靠的企业耗材和试剂供应相结合，每天可以处理多达 10,000 个样本，以优化 SARS-CoV-2 检测的生产力。我可以做到。
• 2021 年 3 月 - Thermo Fisher Scientific 宣布建立战略技术合作伙伴关係，为 Thermo Fisher 的标准化 COVID-19 测试平台开发一个全面的集成软件自动化平台。这种集成将增加测试吞吐量并支持全球医疗保健工作。
• 2021 年 3 月 - 医疗技术先驱 Becton Dickinson 将 BD Kiestra 实验室自动化孵化和成像系统与可能彻底改变微生物实验室处理尿液培养分析的方式相结合，宣布在美国推出尿液培养应用程序。

其他特典

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

内容

第 1 章介绍

• 研究假设和市场定义
• 调查范围

第 2 章研究方法

第 3 章执行摘要

第 4 章市场洞察

• 市场概览
• 工业价值链分析
• 工业吸引力 - 波特五力分析
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
• 评估 COVID-19 对行业的影响

第 5 章市场动态

• 市场促进因素
  • 需要改进海量数据的可重复性和高效管理
  • 需要高度可靠的自动化解决方案来弥补熟练工人的短缺
• 市场抑制因素
  • 中小型组织的采用率下降
  • 高资本要求

第 6 章市场细分

• 按设备/软件
  • 自动液体处理器
  • 自动印版处理机
  • 机械臂
  • 自动存储和检索系统 (ASRS)
  • 软件
  • 分析器
• 按应用领域
  • 药物发现
  • 基因组学
  • 蛋白质组学
  • 临床诊断
  • 其他应用领域
• 区域资讯
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 其他亚太地区
  • 世界其他地区

第 7 章竞争格局

• 公司简介
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Hudson Robotics Inc.
  • Becton Dickinson
  • Synchron Lab Automation
  • Siemens Healthcare
  • Perkinelmer Inc.
  • Honeywell International Inc.
  • Tecan Group Ltd
  • Agilent Technologies

第 8 章投资分析

第 9 章市场机会和未来趋势

The modular laboratory automation market is anticipated to grow at a CAGR of 6.5% over the forecast period. Laboratory automation has transformed the medical laboratory space by steadily replacing semi-automatic and manual methods with fully automated systems. These automation systems are beneficial in sterile environments, wherein human error is significantly reduced and time is saved. Routine laboratory processes, such as testing, screening, etc., are automated. Automation tools can process concurrent requests in real time, showing marked improvement in productivity and throughput.

Key Highlights

• One of the primary reasons expected to promote market expansion shortly is the rise in benefits given by lab automation. A paradigm change from total manual intervention to lab automation has various advantages for clinical laboratories. Reliable outcomes, safe working conditions, higher productivity, and significant time, space, and cost savings are just a few of the primary benefits. Lab automation makes it easier to utilize laboratory equipment for repetitive processes like sample verification and tube labeling and lowering and limiting the physical strain caused by manual chores, which saves money and space in the lab.
• Emerging markets are likely to provide considerable growth possibilities for lab automation product manufacturers and distributors during the projected period. Increasing demand for clinical diagnostic processes, resulting in increasing lab automation equipment sales. Major product manufacturers are expanding their distribution networks and production capabilities in new areas to increase their market share. This presents a profitable potential for laboratory automation.
• Liquid handlers and robotic arms are gradually becoming handy for performing different tasks with increased efficiency in modular laboratory environments. Conversely, the automation tools also handle the demand for the systematic execution of specific tasks, like running ELISA assays.
• In recent years, molecular diagnostic assays have relied significantly on real-time PCR technology, which detects the amplification of DNA in real-time, while PCR is in progress using a fluorescent reporter. More than 75% of clinic molecular diagnostic tests are amenable to real-time PCR procedures. This technology has provoked a new molecular biology market by offering rapid assays for better diagnosis and personalized treatment of complex diseases.
• Further, the use of laboratory automation tools in early cancer detection and increased adoption in microbiology have been the major contributors to the market growth in North America and Europe. MLA (Medical Laboratory Assistants) tools are widely employed for diagnosis in emerging markets like India and China, and the demand for these tools is expected to rise steadily.
• The COVID-19 pandemic has accelerated medicine development and research while putting additional strain on clinical laboratories and pharmaceutical companies. As a consequence of the increased interest in microplate readers, automated liquid handling, and robots, ensuring a shorter TAT has become a priority. On the other hand, the epidemic has resulted in lower revenues and margins for hospitals and health systems, as well as lower expenditures on automation and technology. As a result, the long-term market for modular laboratory automation is impacted.

Key Market Trends

Automated Liquid Handlers Account for the Largest Market Share

• Liquid handlers are usually employed in biochemical and chemical laboratories. Automated liquid handling robots help in dispensing samples and other liquids in laboratories. Automated liquid handlers minimize run times and maximize accuracy. Moreover, liquid handlers are capable of operating across a wide range of volumes, extending into nanolitres, thus proving their usefulness in dispensing operations.
• Leading companies have set the benchmark for the development of automated liquid handlers and are constantly investing in developing premium products to increase productivity effectively. The evolution of the liquid handlers, capable of handling minute volumes of liquids, has contributed to the rapid development of modular lab automation systems in the market.
• According to the Robotic Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, robotic arms, and others, to meet the demand.
• According to Parker, one of the trends in life science robotics is fluidics getting simpler in robotic analyzers. This trend arose because clinical laboratories and hospitals cannot afford an instrument to go down when critical samples are involved. Certain robotic systems that used to have 50 needles on the end of a dispensing unit and lots of tubing increasingly use special valve manifolds that eliminate the need for tubing and result in less chance for failure. The manifolds basically minimize the chance of leakage.

Asia Pacific to Witness Significant Growth Rate

• The Asia-Pacific region is anticipated to witness increased demand for lab automation solutions, primarily owing to the rapid growth in the pharmaceuticals market in this region. The growth can be attributed to the increased investment in pharmaceutical research and development in Asia-Pacific.​
• In the Asia-Pacific region, the prolongation of economic and demographic trends, further healthcare reforms, and the policies articulated in the government's five-year plan are expected to propel the growth of the market. The high-growth market opens new opportunities for the vendors of lab automation solutions to expand their footprint.
• For instance, China, from the pharmaceuticals industry to medical products to consumer health, remains one of the world's most attractive markets and by far the fastest-growing of all the large emerging markets. Though there has been some decline in recent times, it remains a significant market for modular lab automation in the Asia-Pacific region.
• Furthermore, the region is ideal for conducting pharmaceutical research owing to the presence of a large pool of heterogeneous population groups, unlike other continents. This region is preferred the most to outsource pharmaceutical research, owing to the availability of skilled labor and lower cost required in the development of drugs. ​
• Many organizations are adopting modular laboratories, offering low-cost and reliable solutions. Modular laboratory automation is experiencing a growing demand in the market. South Korea is expected to become one of the technologically advanced nations. The increasing adoption of automation and innovations in technology by local companies is expected to boost the growth of the industry.

Competitive Landscape

The modular laboratory automation market is fragmented. The rapid growth in the number of clinical and pre-clinical studies across the world has created a faster imperative in sample analysis. It reduces both machine downtime and manpower. With growing demand, companies are entering the market, making it attractive as well as competitive. Some of the key players in the market are Thermo Fisher Scientific, Danaher Corporation, Becton Dickinson, Siemens Healthcare, Synchron Lab Automation, Honeywell International Inc., Perkinelmer Inc., among others.

• March 2021 - PerkinElmer launched entire workflow solutions for the detection and screening of SARS-CoV-2 RNA, including instruments, reagents, and consumables. The modular automated workstations, combined with a reliable supply of corporate consumables and reagents, can optimize the productivity of SARS-CoV-2 testing by processing up to 10,000 samples per day.
• March 2021 - Thermo Fisher Scientific announced a strategic technology collaboration to develop a comprehensive and integrated software automation platform for Thermo Fisher's standardized COVID-19 Testing Platform. Increased testing throughput and assistance for global healthcare efforts will emerge from the integration.
• March 2021 - Becton, Dickinson, and Company, a pioneer in medical technology, has announced the launch of a Urine Culture Application in conjunction with the BD Kiestra lab automation incubation as well as an imaging system in the United States, which has the potential to revolutionize the way microbiology labs approach urine culture analysis.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definitions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Industry Value Chain Analysis
• 4.3 Industry Attractiveness - Porter's Five Forces Analysis
  • 4.3.1 Bargaining Power of Suppliers
  • 4.3.2 Bargaining Power of Buyers
  • 4.3.3 Threat of New Entrants
  • 4.3.4 Threat of Substitute Products
  • 4.3.5 Intensity of Competitive Rivalry
• 4.4 Assessment of COVID-19 Impact on the Industry

5 MARKET DYNAMICS

• 5.1 Market Drivers
  • 5.1.1 Need for Higher Reproducibility and Effective Management  of Vast Amounts of Data
  • 5.1.2 Need for Reliable Automation Solution to Substitute the Unavailability of Skilled Personnel
• 5.2 Market Restraints
  • 5.2.1 Slower Adoption Rates in Small- and Medium-sized Organizations
  • 5.2.2 High Capital Requirements

6 MARKET SEGMENTATION

• 6.1 By Equipment and Software
  • 6.1.1 Automated Liquid Handlers
  • 6.1.2 Automated Plate Handlers
  • 6.1.3 Robotic Arms
  • 6.1.4 Automated Storage and Retrieval Systems (ASRS)
  • 6.1.5 Software
  • 6.1.6 Analyzers
• 6.2 By Field of Application
  • 6.2.1 Drug Discovery
  • 6.2.2 Genomics
  • 6.2.3 Proteomics
  • 6.2.4 Clinical Diagnostics
  • 6.2.5 Other Fields of Application
• 6.3 By Geography
  • 6.3.1 North America
    • 6.3.1.1 United States
    • 6.3.1.2 Canada
  • 6.3.2 Europe
    • 6.3.2.1 United Kingdom
    • 6.3.2.2 Germany
    • 6.3.2.3 Spain
    • 6.3.2.4 Rest of Europe
  • 6.3.3 Asia Pacific
    • 6.3.3.1 China
    • 6.3.3.2 Japan
    • 6.3.3.3 South Korea
    • 6.3.3.4 Rest of Asia Pacific
  • 6.3.4 Rest of the World

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Thermo Fisher Scientific
  • 7.1.2 Danaher Corporation
  • 7.1.3 Hudson Robotics Inc.
  • 7.1.4 Becton Dickinson
  • 7.1.5 Synchron Lab Automation
  • 7.1.6 Siemens Healthcare
  • 7.1.7 Perkinelmer Inc.
  • 7.1.8 Honeywell International Inc.
  • 7.1.9 Tecan Group Ltd
  • 7.1.10 Agilent Technologies

8 INVESTMENT ANALYSIS

9 MARKET OPPORTUNITIES AND FUTURE TRENDS